Xiaodong Wang insider trades

Open-market stock purchases and sales by Xiaodong Wang, Director at BeOne Medicines Ltd, from SEC Form 4 filings since Nov 16, 2016.

Recent trades

DateStockTradeValue
Oct 13, 2026ONC BeOne Medicines LtdSold$2.5M
Oct 13, 2026ONC BeOne Medicines LtdSold$2M
Oct 13, 2026ONC BeOne Medicines LtdSold$2.3M
Oct 13, 2026ONC BeOne Medicines LtdSold$445K
Oct 13, 2026ONC BeOne Medicines LtdBought (not open market)$1.1M
Oct 13, 2026ONC BeOne Medicines LtdSold$3.6M
Oct 13, 2026ONC BeOne Medicines LtdBought (not open market)—
Sep 28, 2026ONC BeOne Medicines LtdBought (not open market)$1.1M
Sep 28, 2026ONC BeOne Medicines LtdSold$57.1K
Sep 28, 2026ONC BeOne Medicines LtdSold$43K
Sep 28, 2026ONC BeOne Medicines LtdSold$14.4K
Sep 28, 2026ONC BeOne Medicines LtdSold$809K
Sep 28, 2026ONC BeOne Medicines LtdSold$1.5M
Sep 28, 2026ONC BeOne Medicines LtdSold$1.3M
Sep 28, 2026ONC BeOne Medicines LtdSold$1.2M
Sep 28, 2026ONC BeOne Medicines LtdSold$749K
Sep 28, 2026ONC BeOne Medicines LtdSold$5.3M
Sep 28, 2026ONC BeOne Medicines LtdSold$271K
Sep 28, 2026ONC BeOne Medicines LtdBought (not open market)—
Sep 8, 2026ONC BeOne Medicines LtdSold$408K
Sep 8, 2026ONC BeOne Medicines LtdSold$983K
Sep 8, 2026ONC BeOne Medicines LtdSold$527K
Sep 8, 2026ONC BeOne Medicines LtdSold$599K
Sep 8, 2026ONC BeOne Medicines LtdBought (not open market)$1.1M
Sep 8, 2026ONC BeOne Medicines LtdSold$2.6M

Companies traded

  • ONC BeOne Medicines Ltd: 32 sales, last Oct 13, 2026
  • BGNE BeiGene, Ltd: 225 sales, last May 13, 2025

Get free alerts when Xiaodong Wang files a new trade →